Suppr超能文献

2019冠状病毒病所致死亡与凝血参数之间的关联:一项系统评价和荟萃分析研究

The association between mortality due to COVID-19 and coagulative parameters: a systematic review and meta-analysis study.

作者信息

Abdollahi Alireza, Nateghi Saeed, Panahi Zahra, Inanloo Seyed Hassan, Salarvand Samaneh, Pourfaraji Seyed Morteza

机构信息

Department of Pathology, School of Medicine, IKHC, Teheran University of Medical Sciences, Tehran, Iran.

Department of Cardiology, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

BMC Infect Dis. 2024 Dec 2;24(1):1373. doi: 10.1186/s12879-024-10229-y.

Abstract

AIMS AND OBJECTIVES

This systematic review and meta-analysis study evaluated the association between mortality due to COVID-19 and coagulative factors.

METHODS

A systematic search was conducted on electronic databases including PubMed, Scopus, and the Web of Science from the beginning of the pandemic until October 2024 to identify relevant studies on COVID-19 patients and their laboratory findings related to coagulation markers and mortality outcome. Eligibility criteria were defined based on the PICO framework, and data extraction was performed by two authors independently using a standardized sheet. Statistical analysis was accomplished using the random effects model, and heterogeneity among studies was assessed using the I test. R and RStudio were used for statistical analysis and visualization.

RESULTS

Our systematic literature search yielded 6969 studies, with 48 studies meeting the inclusion criteria for our meta-analysis. The mean platelet count was significantly lower in deceased COVID-19 patients compared to survivors (20.58), while activated partial thromboplastin time (aPTT) and fibrinogen levels did not show significant differences. The pooled mean difference of D-Dimer, International Normalized Ratio (INR), and prothrombin time (PT) were significantly lower in survived patients (-2.45, -0.10, and -0.84, respectively). These findings suggest that platelet count, D-Dimer, INR, and PT may serve as potential indicators of mortality in COVID-19 patients.

CONCLUSION

The results of our systematic review and meta-analysis revealed a significant reduction in the pooled platelet count among deceased individuals when compared to survivors. However, no significant distinctions were observed in the pooled mean activated aPTT and fibrinogen levels between the deceased and survivor groups. On the other hand, there were noticeable variations in the pooled estimated mean of INR, PT, and D-Dimer levels, with significantly higher values in the deceased group compared to those who survived.

摘要

目的与目标

本系统评价和荟萃分析研究评估了2019冠状病毒病(COVID-19)所致死亡与凝血因子之间的关联。

方法

从疫情开始至2024年10月,在包括PubMed、Scopus和科学网在内的电子数据库中进行系统检索,以识别关于COVID-19患者及其与凝血标志物和死亡结局相关的实验室检查结果的相关研究。根据PICO框架定义纳入标准,由两名作者独立使用标准化表格进行数据提取。使用随机效应模型进行统计分析,使用I检验评估研究间的异质性。使用R和RStudio进行统计分析和可视化。

结果

我们的系统文献检索共获得6969项研究,其中48项研究符合我们荟萃分析的纳入标准。与幸存者相比,死亡的COVID-19患者平均血小板计数显著更低(20.58),而活化部分凝血活酶时间(aPTT)和纤维蛋白原水平无显著差异。存活患者的D-二聚体、国际标准化比值(INR)和凝血酶原时间(PT)的合并平均差值显著更低(分别为-2.45、-0.10和-0.84)。这些发现表明,血小板计数、D-二聚体、INR和PT可能是COVID-19患者死亡的潜在指标。

结论

我们的系统评价和荟萃分析结果显示,与幸存者相比,死亡个体的合并血小板计数显著降低。然而,死亡组和存活组之间的合并平均活化aPTT和纤维蛋白原水平未观察到显著差异。另一方面,INR、PT和D-二聚体水平的合并估计平均值存在明显差异,死亡组的值显著高于存活者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5072/11610108/1c09a86fcb50/12879_2024_10229_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验